Article Details

ImmunoMet Therapeutics Receives IND Clearance and Orphan Drug Designation from US FDA for ...

Retrieved on: 2021-02-08 16:18:45

Tags for this article:

Click the tags to see associated articles and topics

ImmunoMet Therapeutics Receives IND Clearance and Orphan Drug Designation from US FDA for .... View article details on hiswai:

Excerpt

ImmunoMet is a clinical stage biotechnology company targeting metabolism for the treatment of fibrotic diseases and cancer. ImmunoMet's lead ...

Article found on: www.oaoa.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo